Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Consegna Pharma Inc. operates a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio shows 1 pending office action. This action involves 1 distinct examiner, indicating that the current prosecution is being handled by a single point of contact. The presence of 1 distinct art unit suggests that the technology is being evaluated within a specific technical division.
JANOSKO, CHASITY PAIGE is the busiest examiner for the portfolio, with 1 busiest examiner pending office action. This examiner is responsible for the entire pending workload of 1 pending office action. Practitioners must focus on the specific examination history and preferences of this examiner. The data indicates that the company's current patent activity is highly concentrated within a single art unit and examiner assignment.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JANOSKO, CHASITY PAIGE | 1 | 15.9% | +63.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17776691 | LONG ACTING NMDA ANTAGONISTS | JANOSKO, CHASITY PAIGE | 89d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17776691 | LONG ACTING NMDA ANTAGONISTS | JANOSKO, CHASITY PAIGE | 89d overdue |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17776691 | LONG ACTING NMDA ANTAGONISTS | JANOSKO, CHASITY PAIGE | 1613 | §103 | Non-Final OA | 89d overdue | Pending | May 13, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial